- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
First Cancer-Specific ACO Launches
The best business model for oncology care is not yet obvious to me. But it is crystal clear that innovative new models are being hatched before our eyes: First, the oncology medical home and now, the cancer-specific accountable care organization.
As reported in OT last year, The US Oncology Network had hoped that the federal government would allow cancer-specific ACOs. That idea did not fly. But US Oncology was apparently undaunted: One of its affiliates has announced its own ACO in conjunction with a private insurer and a big health system.
Read the full story: http://hcp.lv/KPnRZs
Source: Oncology Times
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
